Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms
Leukemia
.
2024 Dec;38(12):2727-2730.
doi: 10.1038/s41375-024-02374-9.
Epub 2024 Sep 23.
Authors
Mahmoud Yacout
1
,
Bahga Katamesh
1
,
Yazan Jabban
1
,
Rong He
2
,
David Viswanatha
2
,
Dragan Jevremovic
2
,
Patricia Greipp
2
,
Kurt Bessonen
3
,
Jeanne Palmer
4
,
James Foran
5
,
Antoine Saliba
1
,
Mehrdad Hefazi-Torghabeh
1
,
Kebede Begna
1
,
William Hogan
1
,
Mrinal Patnaik
1
,
Mithun Shah
1
,
Hassan Alkhateeb
1
,
Aref Al-Kali
6
Affiliations
1
Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA.
2
Division of Hematopathology, Mayo Clinic, Rochester, MN, 55905, USA.
3
Division of Molecular Hematology, Mayo Clinic, Rochester, MN, 55905, USA.
4
Division of Hematology, Mayo Clinic, Scottsdale, AZ, 85259, USA.
5
Division of Hematology, Mayo Clinic, Jacksonville, FL, 32224, USA.
6
Division of Hematology, Mayo Clinic, Rochester, MN, 55905, USA. alkali.aref@mayo.edu.
PMID:
39313565
PMCID:
PMC11588644
DOI:
10.1038/s41375-024-02374-9
No abstract available